Source: MarketScreener

XVIVO: Xvivo Perfusion : SORP 2024

(marketscreener.com) The Board of Directors' of XVIVO Perfusion AB proposal for adoption of an incentive programme in the form of performance-based share option rights for the group management and key individuals within the XVIVO group and directed issue of warrants The Board of Directors' of XVIVO Perfusion AB propose that...https://www.marketscreener.com/quote/stock/XVIVO-PERFUSION-AB-14473097/news/Xvivo-Perfusion-SORP-2024-46254834/?utm_medium=RSS&utm_content=20240321

Read full article »
Annual Revenue
$25-100M
Employees
100-250
Christoffer Rosenblad's photo - CEO of XVIVO

CEO

Christoffer Rosenblad

CEO Approval Rating

82/100

Read more